Group 1 - Whitehawk Therapeutics, Inc. (WHWK) shares increased by 23.13 percent to $2.59, gaining $0.48 following the announcement of a multi-year collaboration with Tempus AI [1] - The partnership aims to utilize Tempus' proprietary real-world dataset to enhance biomarker-driven research and support the development of Whitehawk's antibody drug conjugate pipeline for cancer treatment [1] Group 2 - During the trading session, Whitehawk's stock fluctuated between $2.53 and $3.77, with a previous close of $2.11 on the Nasdaq [2] - Trading volume reached 83.47 million shares, significantly higher than the average of 0.11 million shares [2] - Over the past 52 weeks, Whitehawk Therapeutics shares have traded within a range of $1.39 to $3.81 [2]